Human neutrophil collagenase MMP-8 in peri-implant sulcus fluid and its inhibition by clodronate

Journal of Dental Research

Volumn 76, Issue 9, 1997, Pages 1529-1537

  Teronen, O ^a   Konttinen, Y T ^c   Lindqvist, C ^a   Salo, T ^b   Ingman, T ^b   Lauhio, A ^b   Ding, Y ^b   Santavirta, S ^b   Sorsa, T ^b  

^a Institute of Dentistry   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF OULU   (Finland)

Author keywords

Clodronate bisphosphonates; Gingival crevicular fluid; Inhibition; Metalloproteinases; Peri implant sulcus fluid

Indexed keywords

ANTIINFECTIVE AGENT; AUROTHIOGLUCOSE; BIOLOGICAL MARKER; CALCIUM; CLODRONIC ACID; COLLAGENASE; DOXYCYCLINE; ENZYME INHIBITOR; NEUTROPHIL COLLAGENASE;

ADULT; ARTHRITIS; ARTICLE; BONE REMODELING; COMPARATIVE STUDY; CONNECTIVE TISSUE DISEASE; DENTAL SURGERY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; GINGIVITIS; HUMAN; IMMUNOBLOTTING; METABOLISM; MIDDLE AGED; OSTEOLYSIS; PERIODONTAL DISEASE; PERIODONTAL LIGAMENT; PERIODONTITIS; TOOTH IMPLANTATION;

ADULT; ANTI-BACTERIAL AGENTS; ARTHRITIS; AUROTHIOGLUCOSE; BIOLOGICAL MARKERS; BONE REMODELING; BONE RESORPTION; CALCIUM; CLODRONIC ACID; COLLAGENASES; CONNECTIVE TISSUE DISEASES; DENTAL IMPLANTS; DENTAL RESTORATION FAILURE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXYCYCLINE; ENZYME ACTIVATION; ENZYME INHIBITORS; GINGIVAL CREVICULAR FLUID; HUMANS; IMMUNOBLOTTING; MATRIX METALLOPROTEINASE 8; MIDDLE AGED; OSTEOLYSIS; PERIODONTAL DISEASES; PERIODONTAL LIGAMENT; PERIODONTITIS; TOOTH MOBILITY;

EID: 0031226196     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/00220345970760090401     Document Type: Article

References (54)

1. Ainamo J, Barmes D, Beagrie G, Cutress T, Martin J, SardoInfirri J (1982). Development of the World Health Organization (WHO) community periodontal index of treatment needs (CPITN). Int Dent J 32:281-291.
2. Apse P, Ellen RP, Overall CM, Zarb GA (1989). Microbiota and crevicular fluid collagenase activity in the osteointegrated dental implant sulcus: A comparison of sites in edentulous and partially edentulous patients. J Periodont Res 24:96-105.
3. Branemark PI (1985). Introduction to osseointegration. In: Tissue integrated prostheses, osseointegration in clinical dentistry. Zarb GA, Albrektsson T, editors. Chicago: Quintessence Publishing Company Inc., pp. 11-76.
4. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, et al. (1993). Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 4:197-250.
5. Brunsvold MA, Chaves ES, Kornman KS, Aufdemorte TB, Wood R (1992). Effects of a bisphosphonate on experimental periodontitis in monkeys. J Periodontol 63:825-830.
6. Chubinskaya S, Huch K, Mikecz K, Cs-Szabo G, Hasty KA, Kuettner KE, et al. (1996). Chondrocyte matrix metalloproteinase-8: up-regulation of neutrophil collagenase by interleukin-1 beta in human cartilage from knee and ankle joints. Lab Invest 74:232-240.
7. DeCarlo A Jr (1994). Matrix metalloproteinase activation and induction in keratinocytes by a purified thiol-proteinase from Porpliyronwnas gingivalis (PhD thesis/dissertation). Birmingham, AL: University of Alabama, pp. 1-79.
8. Evanson JM, Jeffrey JJ, Krane SM (1967). Human collagenase: identification and characterization of an enzyme from rheumatoid synovium in culture. Science 158:499-502.
9. Fleisch H (1991). Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease. Drugs 42:919-944.
10. Frost HM (1983). In: Bone histomorphometry: Techniques and interpretation. Reckker RR, editor. Boca Raton, FL: CRC Press, pp. 109-123.
11. Fosang AJ, Last K, Neame PJ, Murphy G, Knäuper V, Tschesche H, et al. (1994). Neutrophil collagenase (MMP-8) cleaves at the aggrecanase site E373-A374 in the interglobular domain of cartilage aggrecan. Biochem J 304:347-351.
12. Fosang AJ, Last K, Knäuper V, Murphy G, Neame PJ (1996). Degradation of cartilage aggrecan by collagenase-3 (MMP-13). FEBS Lett 380:17-20.
13. Fullmer HM, Gibson WA, Lazarus GS, Bladen HA, Whedon KA (1969). The origin of collagenase in periodontal tissues of man. J Dent Res 48:646-651.
14. Gangbar S, Overall CM, McCulloch CA, Sodek J (1990). Identification of polymorphonuclear leukocyte collagenase and gelatinase activities in mouthrinse samples: correlation with periodontal disease activity in adult and juvenile periodontitis. J Periodont Res 25:257-267.
15. Goldberg GI, Wilhelm SM, Kronberger A, Bauer EA, Grant GA, Eisen AZ (1986). Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein. J Biol Cliem 261:6600-6605.
16. Golub LM, Ciancio S, Ramamurthy NS, Leung M, McNamara TF (1990). Low-dose doxycycline therapy: effect on gingival and crevicular fluid collagenase activity in humans. J Periodont Res 25:321-330.
17. Golub LM, Suomalainen K, Sorsa T (1992). Host modulation with tetracyclines and their chemically modified analogues. Curr Opin Dent 2:80-90.
18. Golub LM, Sorsa T, Lee HM, Ciancio S, Sorbi D, Ramamurthy NS, et al (1995). Doxycycline inhibits neutrophil (PMN)-type matrix metalloproteinases in human adult periodontitis gingiva. J Clin Periodontol 22:100-109.
19. Greemvald RA, Golub LM, Lavietes B, Ramamurthy NS, Gruber B, Laskin RS, et al. (1987). Tetracyclines inhibit human synovial collagenase i;i vivo and in vitro. J Rlienmatol 14:28-32.
20. Greenwald RA, Moak SA, Ramamurthy NS, Golub LM (1992). Tetracyclines suppress matrix metalloproteinase activity in adjuvant arthritis and in combination with flurbiprofen, ameliorate bone damage. J Rheumatol 19:927-938.
21. Harris ED Jr, DiBona DR, Krane SM (1969). Collagenase in synovial fluid. J Clin Invest 48:2104-2113.
22. Igarashi K, Adachi H, Mitani H, Shinoda H (1996). Inhibitory effect of the topical administration of a bisphosphonate (risedronate) on root resorption incident to orthodontic tooth movement in rats. J Dent Res 75:1644-1649.
23. Ingman T, Könönen M, Konttinen YT, Ylipaavalniemi P, Ding Y, Tervahartiala T, et ni. (1994). Proteolytic enzymes in sulcular fluid of osseointegrated dental implant patients in comparison to periodontitis patients and healthy control subjects. In: Biological mechanisms of tooth eruption, resorption and replacement by implants. Davidovitch Z, editor. Boston, MA: Harvard Society for the Advancement of Orthodontics, pp. 681-686.
24. Ingman T, Tervahartiala T, Ding Y, Tschesche H, Haerian A, Kinane DF, et al. (1996). Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients. J Clin Periodontol 23:1127-1132.
25. Jeffcoat MK, Reddy MS (1996). Alveolar bone loss and osteoporosis: Evidence for a common mode of therapy using the bisphosphonate alendronate. In: Biological mechanisms of tooth movement and craniofacial adaptation. Davidovitch Z, Norton LA, editors. Boston, MA: Harvard Society for the Advancement of Orthodontics, pp. 365-373.
26. Konttinen YT, Lindy O, Kemppinen P, Saari H, Suomalainen K, Vauhkonen M, et al. (1991). Collagenase reserves in polymorphonuclear leukocytes from synovial fluid and peripheral blood of patients with rheumatoid arthritis. Matrix 11:296-301.
27. Lauhio A, Sorsa T, Lindy O, Suomalainen K, Saari H, Golub LM, et al. (1992). The anticollagenolytic potential of lymecycline in the treatment of reactive arthritis. Arthrit Rheum 35:195-198.
28. Lauhio A, Konttinen YT, Tschesche H, Nordström D, Salo T, Lähdevirta J, et al. (1994a). Reduction of matrix metalloproteinase 8-neutrophil collagenase levels during long-term doxycycline treatment. Antimicrob Agents Oiemother 38:400-402.
29. Lauhio A, Salo T, Ding Y, Konttinen YT, Nordström D, Tschesche H, et al. (1994b). In vivo inhibition of human neutrophil collagenase (MMP-8) activity during long-term combination therapy of doxycycline and non-steroidal antiinflammatory drugs (NSAID) in acute reactive arthritis. Clin Exp Immunol 98:21-28.
30. Lauhio A, Salo T, Tjäderhane L, Lähdevirta J, Golub LM, Sorsa T (1995). Tetracyclines in treatment of rheumatoid arthritis. Lancet 346:645-646.
31. 1-antitrypsin. Biocliem J 270:809-814.
32. Overall CM, Sodek J, McCulloch CA, Birek P (1991). Evidence for polymorphonuclear leukocyte collagenase and 92-kilodalton gelatinase in gingival crevicular fluid. Infect Immun 59:4687-4692.
33. Reddy MS, Weatherford TW 3rd, Smith CA, West BD, Jeffcoat MK, Jacks TM (1995). Alendronate treatment of naturally occurring periodontitis in beagle dogs. J Periodontol 66:211-217.
34. Salo T, Kylmäniemi M, Helaakoski T, Virkkunen J, Ding Y, Konttinen YT, et al. (1995). MMP-8/neutrophil collagenase mRNA may also be expressed in other cells than PMNs (abstract). J Dent Res 74(Spec Iss):1036.
35. Santavirta S, Sorsa T, Konttinen YT, Saari H, Eskola A, Eisen ZA (1993). Role of mesenchymal collagenase in the loosening of total hip prosthesis. Clin Orthop Rel Res 290:206-215.
36. Sato M, Grasser W, Endo N, Akins R, Simmons H, Thompson DD, et al. (1991). Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure. J Clin Invest 88:2095-2105.
37. Sorsa T (1989). Human leukocyte collagenase: purification, activation and its role in periodontal collagen degradation (PhD thesis/dissertation). Helsinki, Finland: University of Helsinki, pp. 1-62.
38. Sorsa T, Uitto V-J, Suomalainen K, Vauhkonen M, Lindy S (1988). Comparison of interstitial collagenases from human gingiva, sulcular fluid and polymorphonuclear leukocytes. J Periodont Res 23:386-393.
39. Sorsa T, Ding Y, Salo T, Lauhio A, Teronen O, Ingman T, et al. (1994). Effects of tetracyclines on neutrophil, gingival, and salivary collagenases. A functional and Western-blot assessment with special reference to their cellular sources in periodontal diseases. .Ann NY Acad Sci 732:112-131.
40. Sorsa T, Lukinmaa P-L, Westerlund U, Ingman T, Ding Y, Tschesche H, et al. (1996). The expression, activation, and chemotherapeutic inhibition of matrix metalloproteinase-8 (neutrophil collagenase/collagenase-2) in inflammation. In: Biological mechanisms of tooth eruption, resorption and replacement by implants. Davidovitch Z, editor. Boston, MA: Harvard Society for the Advancement of Orthodontics, pp. 317-323.
41. Sorsa T, Salo T, Koivunen E, Tyynelä J, Teronen O, Heikkilå P, et al. (1997). Activation of progelatinases by human tumor-associated trypsin-2. J Biol Client (in press).
42. Suomalainen K, Sorsa T, Golub LM, Ramamurthy N, Lee H-M, Uitto V-J, et al. (1992). Specificity of the anti-collagenase action of tetracyclines: relevance to their anti-inflammatory potential. Antimicrob Agents Chemolher 36:227-229.
43. Takagi M, Santavirta S, Konttinen YT, Lindy O, Sorsa T, Kurvinen H, el al. (1994a). Proteolytic potential of matrix metalloproteinases and serine proteinases in the host response to THR endoprosthesis. Bioceramics 7:311-316.
44. Takagi M, Konttinen YT, Santavirta S, Sorsa T, Eisen AZ, Nordsletten L, et al. (1994b). Extracellular matrix metalloproteinases around loose total hip prostheses. Acta Orthop Scand 65:281-286.
45. Teronen O, Salo T, Laitinen J, Törnwall J, Ylipaavalniemi P, Konttinen YT, et al. (1995). Characterization of interstitial collagenases in jaw cyst walls. Eur J Oral Sci 103:141-147.
46. Teronen O, Husa V, Lindqvist C, López-Òtin C, Salo T, Konttinen YT, et al. (1997a). MMP-13 in peri-implant sulcus fluid (PISF) of different patient groups (abstract). J Dent Res 76(Spec Iss):144.
47. Teronen O, Konttinen YT, Lindqvist C, Salo T, Ingman T, Lauhio A, et al. (1997b). Inhibition of matrix metalloproteinase-1 by dichloromethylene bisphosphonate (clodronate). Calcif Tissue Int (in press).
48. Teronen O, Sorsa T, Salo T (1997c). Inhibition of the degradation of connective tissue matrix protein components in mammals. .US Patent 5,652,227.
49. Tonetti MS, Freiburghaus K, Lang NP, Bickel M (1993). Detection of interleukin-8 and matrix metalloproteinases transcripts in healthy and diseased gingival biopsies by RNA/PCR. J Periodont Res 28:511-513.
50. Turto H, Lindy S, Uitto VJ, Wegelius O, Uitto J (1977). Human leukocyte collagenase: characterization of enzyme kinetics by a new method. Anal Biochem 83:557-569.
51. Weiss SJ (1989). Tissue destruction by neutrophils. N Engl J Med 320:365-376.
52. Westerlund U, Ingman T, Lukinmaa P-L, Salo T, Kjeldsen L, Borregaard N, et al. (1996). Human neutrophil gelatinase and associated lipocalin in adult and localized juvenile periodontitis. J Dent Res 75:1553-1563.
53. Woessner JF Jr (1991). Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:2145-2154.
54. Yu LP Jr, Smith GN Jr, Brandt KD, Myers SL, O'Connor BL, Brandt DA (1992). Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline. Arthrit Rheum 35:1150-1159.